Roche Corleen M. 4
4 · Immunome Inc. · Filed Apr 21, 2021
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Roche Corleen M.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-19+125,000→ 125,000 totalExercise: $27.53Exp: 2031-04-19→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on April 19, 2022, and the remaining 75% of shares subject to the option shall vest in equal monthly installments for the 36 months thereafter.